Skip to content

A study for critical gut microbiome in the formation of renal calcium oxalate stones

A study for critical gut microbiome in the formation of renal calcium oxalate stones

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021756
Enrollment
Unknown
Registered
2019-03-08
Start date
2019-03-12
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal stones

Interventions

Case series:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20-70 years; 2. Patients diagnosed as renal calculi by KUB, ultrasound of urinary system or abdominal CT.

Exclusion criteria

Exclusion criteria: 1. Known factors that may promote the formation of kidney stones: (1) Infectious stones: history of urinary tract infection and used antibiotics within one year; (2) Abnormality of the urinary system: such as UPJO, dilated hydronephrosis of the renal collection system, stricture of the ureter, isolated kidney, repeated kidney, Horseshoe kidney, medullary sponge kidney, polycystic kidney disease (PKD), calyceal diverticulum, ureteral hernia, bladder and ureteral reflux; (3) Metabolic diseases: such as hyperuricemia, homocysteinemia and renal tubular acidosis; (4) Endocrine diseases: such as osteoporosis, thyroid diseases (hyperthyroidism, hyperparathyroidism); (5) Long-term use of drugs easy to cause kidney stones: such as aminophenetridine, HIV drugs (indenavir), magnesium silicate, sulfonamides, acetazolamide, vitamin C, vitamin D, corticosteroids; (6) Long-term use of drugs affecting urine electrolytes: diuretics (loop diuretics, thiazide), citrate; 2. Known factors that may affect intestinal flora: (1) Antibiotics or immunosuppressants were used within 3 months before fecal sampling; (2) Diseases of the digestive system: such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), digestive tract infection, and tumors of the digestive system; (3) History of intestinal surgery: such as subtotal intestinal resection; (4) Autoimmune diseases; (5) History of diarrhea or constipation within 1 month.

Design outcomes

Primary

MeasureTime frame
Composition of gut micribiome;

Countries

China

Contacts

Public ContactKunjie Wang

Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University

wangkj@scu.edu.cn+86 18980601848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026